CTEP Branches and Offices
Lynne Huang, Ph.D., J.D.
Senior Intellectual Property Adviser
Dr. Lynne Huang joined the NCI Division of Cancer Treatment and Diagnosis (DCTD) in 2019. Prior to joining DCTD/CTEP, she served as Technology Transfer Manager at the NCI Technology Transfer Center (TTC) where she was responsible for handling various technology transfer-related agreements and invention patenting/licensing matters. Dr. Huang primarily takes the lead in reviewing and negotiating a variety of transactional or collaborative agreements for meeting the overall needs of CTEP clinical programs, including Precision Medicine Initiatives, and provides expert guidance and advice as necessary for IP and data protection. Dr. Huang works closely with multiple branches within DCTD, extramural clinical networks/sites, NCI contractors, and NCI pharmaceutical collaborators, to ensure that the terms of any agreements/contracts reflect current processes of programs and policy requirements. Dr. Huang received her Ph.D. in infectious diseases and pathology from the University of Florida and her J.D. from the University of Maryland Francis King Carey School of Law. She is also a registered patent practitioner before the United States Patent and Trademark Office (USPTO).
About the Branch Chief
Bhanu Ramineni, M.S., M.S., became the Chief of the Regulatory Affairs Branch in October 2019. She joined the Drug Regulatory Group in the branch in 2010. She holds two Master's degrees: one in Environmental Sciences from Nagarjuna University, India, and a second one in Biochemistry and Molecular Biology with a specialization in Biotechnology from Georgetown University. Ms. Ramineni comes with significant experience in FDA Regulatory Affairs, as well as preclinical and clinical development of vaccines with a special focus in immunology.
More…